Genomtec S.A. (WAR:GMT) — Market Cap & Net Worth
Market Cap & Net Worth: Genomtec S.A. (GMT)
Genomtec S.A. (WAR:GMT) has a market capitalization of $20.65 Million (zł75.02 Million) as of June 19, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #25023 globally and #252 in its home market, demonstrating a 1.63% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genomtec S.A.'s stock price zł4.98 by its total outstanding shares 15064634 (15.06 Million). Review how much debt does Genomtec S.A. carry to assess the company's total debt and financial obligations.
Genomtec S.A. Market Cap History: 2021 to 2026
Genomtec S.A.'s market capitalization history from 2021 to 2026. Data shows change from $38.77 Million to $20.65 Million (-17.34% CAGR).
Genomtec S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genomtec S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
32587.59x
Genomtec S.A.'s market cap is 32587.59 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $38.77 Million | $219.00K | -$7.12 Million | 177.01x | N/A |
| 2022 | $48.18 Million | $40.00K | -$11.93 Million | 1204.41x | N/A |
| 2023 | $44.98 Million | $1.00K | -$9.01 Million | 44984.15x | N/A |
| 2024 | $32.59 Million | $1.00K | -$11.21 Million | 32587.59x | N/A |
Competitor Companies of GMT by Market Capitalization
Companies near Genomtec S.A. in the global market cap rankings as of June 19, 2026.
Key companies related to Genomtec S.A. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Genomtec S.A. Historical Marketcap From 2021 to 2026
Between 2021 and today, Genomtec S.A.'s market cap moved from $38.77 Million to $ 20.65 Million, with a yearly change of -17.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł20.65 Million | +31.05% |
| 2025 | zł15.75 Million | -51.65% |
| 2024 | zł32.59 Million | -27.56% |
| 2023 | zł44.98 Million | -6.63% |
| 2022 | zł48.18 Million | +24.28% |
| 2021 | zł38.77 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Genomtec S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.65 Million USD |
| MoneyControl | $20.65 Million USD |
| MarketWatch | $20.65 Million USD |
| marketcap.company | $20.65 Million USD |
| Reuters | $20.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Genomtec S.A.
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analysi… Read more